Treatment Characteristics and Outcomes of Patients With Chronic/Small Lymphocytic Leukemia (CLL) Treated With Venetoclax and Bruton Tyrosine Kinase Inhibitor (BTKi) Combination Therapies
Year: 2024
Type: article
Authors: Hande H. Tuncer, Nilanjan Ghosh, Isabelle Fleury, Lori A. Leslie, Beenish S. Manzoor, Nicole Lamanna, Toby A. Eyre, Brian T. Hill, Jennifer R. Brown, Wendy Sinai, Catherine C. Coombs, Chaitra Ujjani, Lindsey E. Roeker, Nnadozie Emechebe, Paul M. Barr, Matthew S. Davids, Nicolas Martinez-Calle, Joanna M. Rhodes, Frederick Lansigan, Laurie Pearson, Yun Choi, Stephen J. Schuster, Alan P. Skarbnik, Bita Fakhri, Michael Coyle, Deborah M. Stephens, Meghan C. Thompson, Christopher E. Jensen, Steven E. Marx, Dureshahwar Jawaid, Anna Schuh, Irina Pivneva, Talissa Watson, Annie Guerin, Mazyar Shadman
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4401878501